ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981

Breast Cancer Report To The Profession Suddenly Is a Report To The Nation; Treatment Progress Noted

October 4, 1974

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003